Subscribe To
PRGO / 32 Upcoming Dividend Increases Including 2 Dividend Kings
PRGO News
By Market Watch
August 30, 2023
FDA warns three baby-formula makers about production violations
The U.S. Food and Drug Administration said Wednesday it has sent warning letters to three baby-formula makers as part of what the agency called enhanc more_horizontal
By Seeking Alpha
August 30, 2023
The Prognosis For Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions after recently divesting its prescription businesses. Perrigo stock is rea more_horizontal
By PRNewsWire
August 24, 2023
Perrigo to Attend Upcoming Consumer Investor Conferences
DUBLIN , Aug. 24, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that CFO E more_horizontal
By Seeking Alpha
August 8, 2023
Perrigo Company plc (PRGO) Q2 2023 Earnings Call Transcript
Perrigo Company plc (NYSE:PRGO ) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Brad Joseph - Vice President, Investo more_horizontal
By Zacks Investment Research
August 8, 2023
Perrigo (PRGO) Beats on Q2 Earnings & Sales, Reiterates '23 View
Perrigo (PRGO) reports encouraging second-quarter 2023 results. Management reaffirms the financial guidance for 2023. more_horizontal
By Zacks Investment Research
August 8, 2023
Perrigo (PRGO) Q2 Earnings and Revenues Beat Estimates
Perrigo (PRGO) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings more_horizontal
By PRNewsWire
July 25, 2023
Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth Conference
DUBLIN , July 25, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it pl more_horizontal
By The Motley Fool
July 21, 2023
With a Big Catalyst in Hand, Is Perrigo Company a Buy?
Perrigo's birth control pill, Opill, can now be sold without a prescription. It'll likely start to nibble on the market shares of most other contracep more_horizontal